Mallinckrodt to acquire Sucampo Pharmaceuticals for $1.2bn
The transaction amount includes Sucampo’s debt of $360m assumed by the UK-based Mallinckrodt. Amitiza (lubiprostone) has the approvals of the US Food and Drug Administration (FDA) for three
AstraZeneca has received approval from the Emirates Drug Establishment (EDE) in the UAE for Baxfendy, a medicine using the active ingredient baxdrostat, for uncontrolled hypertension.
The European Commission has approved Alecensa (alectinib) as first-line treatment in ALK-positive lung cancer, while the US Food and Drug Administration (FDA) approved Perjeta (pertuzumab), in combination with Herceptin (trastuzumab) and
Under the agreement, vTv has granted Huadong Pharmaceutical an exclusive license to develop, manufacture and commercialize vTv Therapeutics’ GLP-1r agonist program in China, Hong Kong, Macau, Taiwan, Thailand,
This ongoing study evaluated upadacitinib (ABT-494), an investigational oral JAK1-selective inhibitor, as a monotherapy treatment in patients with moderate to severe rheumatoid arthritis (RA) who did not adequately
Under the deal, the partners will assess Array's MEK inhibitor binimetinib in combination with Pfizer's investigational PARP inhibitor talazoparib and human anti-PD-L1 IgG1 monoclonal antibody avelumab. They will evaluate
The collaboration is part of Boehringer Ingelheim's Research Beyond Borders (RBB) initiative that explores emerging science and technologies for and beyond its core therapeutic areas to create new